Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (22826)	6/29/1998 9:26:00 AM
From: dwc	Read Replies (1) \| Respond to of 32384

Does anyone know if the folks in SD are still planning on putting up a website?

To: Henry Niman who wrote (22826)	6/29/1998 2:03:00 PM
From: Robert L. Ray	Read Replies (9) \| Respond to of 32384

Please excuse me if the answer to this is obvious. I'm just making sure I've got the right feel of things. Is the potential market for Targretin gel & capsules much greater than the potential market for Panretin gel & capsules?? It would seem to me that Targretin has a much greater potential. Also isn't the incidence of KS much lower now in AIDS patients since protease inhibitors came on the scene? If so then that would seem to limit the market potential of Panretin. Also could you give me a little background info on the abstracts you post? For example at the bottom of the last one it says presentation Date July 2, Hall VII. So the abstract your posting could be considered a summery of a more lenthy presentation by a LGND employee destined to take place on July 2 in Hall 7 ? Is Hall 7 a big room of some sort that is on the LGND premises? Who is normally in attendance at these presentations? Is it limited to employees or are others in attendence? Is there a Q & A after the presentations? Do most other biotechs release abstracts about their progress such as the Lgnd abstracts you post?